Yuhan Corp 000100
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- KRW 73,200.00
- Day Range
- KRW 71,900.00–73,800.00
- 52-Week Range
- KRW 52,285.71–84,190.48
- Bid/Ask
- KRW 72,300.00 / KRW 72,400.00
- Market Cap
- KRW 5.34 Tril
- Volume/Avg
- 334,254 / 528,910
Key Statistics
- Price/Earnings (Normalized)
- 53.37
- Price/Sales
- 2.89
- Dividend Yield (Trailing)
- 0.61%
- Dividend Yield (Forward)
- 0.61%
- Total Yield
- 0.76%
Company Profile
Yuhan Corp is a pharmaceutical company. The core business of the company is classified as primary and specialty care, dietary supplement, household and animal care, and contract manufacturing of active pharmaceutical ingredients. Yuhan offers one-stop custom synthesis services from research and development to commercial production of active pharmaceutical products (APIs) and intermediates for the following disease treatments: antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds for international markets.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 1,972
- Website
- http://www.yuhan.co.kr
Comparables
Valuation
|
Metric
|
000100
|
008930
|
016580
|
|---|---|---|---|
Price/Earnings (Normalized) | 53.37 | 21.68 | 7.11 |
Price/Book Value | 2.58 | 2.84 | 0.59 |
Price/Sales | 2.89 | 1.79 | 0.92 |
Price/Cash Flow | 35.17 | 36.53 | 5.43 |
Price/Earnings
000100
008930
016580
Financial Strength
|
Metric
|
000100
|
008930
|
016580
|
|---|---|---|---|
Quick Ratio | 1.54 | 0.36 | 3.93 |
Current Ratio | 2.15 | 0.69 | 5.30 |
Interest Coverage | 20.59 | 13.78 | 1,345.19 |
Quick Ratio
000100
008930
016580
Profitability
|
Metric
|
000100
|
008930
|
016580
|
|---|---|---|---|
Return on Assets (Normalized) | 5.71% | 10.01% | 7.92% |
Return on Equity (Normalized) | 7.43% | 15.05% | 8.87% |
Return on Invested Capital (Normalized) | 6.50% | 12.80% | 7.89% |
Return on Assets
000100
008930
016580
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Yjczljpzj | Rptjym | $71.2 Bil | |
ZTS
| Zoetis Inc Class A | Xncnnnpyqm | Yldd | $68.3 Bil | |
HLN
| Haleon PLC ADR | Dvjzbyxzh | Yxhx | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Zjrnkszz | Zqpf | $14.5 Bil | |
VTRS
| Viatris Inc | Kxmjdxhy | Pswrq | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Ghnsjdhz | Pzx | $11.9 Bil | |
CTLT
| Catalent Inc | Vprlxhk | Zqfbpcl | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Zxczvrgn | Wkz | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Gtvfsvhv | Nlmy | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Gqxggkmlz | Kshntg | $3.5 Bil |